Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Image source, Getty Images By Jennifer Clarke BBC News Prime Minister Rishi Sunak robustly defended the Eat Out to Help Out Scheme he implemented as chancellor during the pandemic in his evidence to the Covid inquiry. Earlier, former Prime Minister Boris Johnson admitted he had underestimated the scale and the challenge of coronavirus. The inquiry’s…
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
Rupert Johnston was left brain damaged after a car crash, but his prolific musical ability lives on.
The last bedtime of 17-month-old Hayden Fell’s life was heartbreakingly normal. Crib video shows the toddler in pajamas playing happily as his parents and sister sang “Wheels on the Bus” with his twin brother. The next morning, Hayden’s dad couldn’t wake him. The tot had become one of several hundred seemingly healthy U.S. toddlers and…
Although U.S. consumers buy products on the assumption that they are safe, potentially dangerous items often make it past regulators and into retailers. In 2023, the year began and ended with recalls and warnings involving products that can be deadly for children. Here’s a look at some products recalled last year that consumers should be…
Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access. The company’s direct-to-consumer push announced Thursday, the first of its kind for a big drugmaker,…